About Kate Humphrey
Articles Written by Kate Humphrey
GSK’s Tesaro Acquires Alteogen’s ALT-B4
GSK announced on January 20 that its portfolio company, Tesaro, will acquire Alteogen’s novel hyaluronidase enzyme ALT-B4 for $20 million. Alteogen developed ALT-B4 using its bespoke Hybrozyme technology, which the company notes was designed to boost the... Read More »
Summit Spine & Joint Centers Acquires Savannah Pain Management and Savannah Pain Center
Summit Spine & Joint Centers, backed by private equity firm Wellspring Capital Management, announced on January 20 that it acquired Savannah Pain Management and Savannah Pain Center. Run by Dr. Keith A. Kirby, MD., Savannah Pain Management and Savannah Pain... Read More »
Proactive MD Reports Third Transaction of 2026
On January 16, Proactive MD announced that it acquired undisclosed allergy specialist practices in Virginia. Terms were not disclosed. Proactive MD is a value-based care provider dedicated to transforming healthcare for patients, employers and health plan... Read More »
GSK Acquires Rapt Therapeutics For $2.2 Billion
In its first transaction of the year, GSK Plc, announced that it acquired Rapt Therapeutics, Inc. for $58 per share. That price equates to an aggregate equity value of $2.2 billion, according to GSK, which added that the upfront investment net of cash acquired... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
